Literature DB >> 11091197

Intracellular function in rehydrated lyophilized platelets.

T H Fischer1, E P Merricks, K E Russell, R A Raymer, G C White, A P Bode, T C Nichols, M S Read.   

Abstract

This study aimed to evaluate the effect of cross-linking and lyophilization on intracellular signalling processes in rehydrated, lyophilized (RL) platelets, which are under development as a platelet substitute for transfusion. Exposure of RL platelets to thrombin resulted in enhanced phosphorylation of several proteins, including 18 kDa and 42 kDa kinase substrates that were shown to be the substrates of myosin light chain and protein kinase C respectively. Cross-linking and lyophilization depleted the platelets of free cytoplasmic ADP and ATP, but had less effect on protein-bound nucleotides. The surface membrane of RL platelets was found to be permeable to poly dT probes less than approximately 3 kDa in size; larger nucleotide probes and proteins did not penetrate the surface membrane. Taken together, our results indicate that RL platelets retain some of the haemostatic stimulus-response functions of fresh platelets and are capable of feedback amplification in coagulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091197     DOI: 10.1046/j.1365-2141.2000.02343.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  Novel blood derived hemostatic agents for bleeding therapy and prophylaxis.

Authors:  Shailaja Hegde; Yi Zheng; Jose A Cancelas
Journal:  Curr Opin Hematol       Date:  2022-08-03       Impact factor: 3.218

2.  The interaction of factor VIIa with rehydrated, lyophilized platelets.

Authors:  Thomas H Fischer; Alisa S Wolberg; Arthur P Bode; Timothy C Nichols
Journal:  Platelets       Date:  2008-05       Impact factor: 3.862

3.  Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities.

Authors:  Viviana P Montecinos; Claudio H Morales; Thomas H Fischer; Sarah Burns; Ignacio F San Francisco; Alejandro S Godoy; Gary J Smith
Journal:  J Cell Mol Med       Date:  2015-03-04       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.